This search looks for keywords in all of the website’s content. Search tips
Filter by
- Agenda(1)
- Annex to CHMP highlights(0)
- Annual Report(0)
- Application withdrawal assessment report(0)
- Committee meeting report(0)
- COVID-19 vaccine safety update(0)
- Direct healthcare professional communication(0)
- EPAR - All authorised presentations(0)
- EPAR - Amended Product Information(0)
- EPAR - Assessment report - Variation(0)
- EPAR - Assessment report on maintenance of orphan designation - Initial authorisation(0)
- EPAR - Assessment report on maintenance of orphan designation - Post-authorisation(0)
- EPAR - Conditions imposed on member states for safe and effective use(0)
- EPAR - Full risk management plan(0)
- EPAR - Overview(0)
- EPAR - Paediatric investigation plan compliance statement(0)
- EPAR - Procedural steps taken and scientific information after authorisation(0)
- EPAR - Procedural steps taken before authorisation(0)
- EPAR - Product Information(0)
- EPAR - Public assessment report(0)
- EPAR - Risk-management-plan summary(0)
- EPAR - Scientific conclusion(0)
- EPAR - Scientific Discussion(0)
- EPAR - Scientific Discussion - Variation(0)
- EPAR - Steps taken after authorisation when a cutoff date has been used(0)
- Herbal - Call for data(0)
- Herbal - Herbal monograph(0)
- Herbal - HMPC assessment report(0)
- Herbal - HMPC opinion on a European Union herbal monograph(0)
- Herbal - List of references supporting the assessment report(0)
- Herbal - Overview of comments received during consultation(0)
- Herbal - Summary of assessment report for the public(0)
- Herbal – European Union herbal monograph(0)
- Herbal – European Union list entry(0)
- Leaflet(0)
- Maximum Residue Limits - Divergent opinion(0)
- Maximum Residue Limits - Opinion(0)
- Maximum Residue Limits - Report(0)
- Maximum Residue Limits - Summary of opinion(0)
- Medicine QA(0)
- Medicines under additional monitoring(0)
- Minutes(1)
- Newsletter(0)
- Opinion outside EU - All presentations(0)
- Opinion outside EU - Assessment report - Variation(0)
- Opinion outside EU - Medicine questions and answers(0)
- Opinion outside EU - Procedural steps taken and scientific information after opinion(0)
- Opinion outside EU - Procedural steps taken before opinion(0)
- Opinion outside EU - Product information(0)
- Opinion outside EU - Public assessment report(0)
- Opinion outside EU - Risk-management-plan summary(0)
- Opinion outside EU - Scientific discussion(0)
- Opinion outside EU - Summary for the public(0)
- Opinion outside EU - Summary of opinion(0)
- Opinion outside EU - Summary of opinion - Initial authorisation(0)
- Opinion outside EU - Withdrawal assessment report(0)
- Orphan designation(0)
- Orphan review(0)
- Other(0)
- Overview of comments(0)
- Parallel distribution(0)
- Periodic safety update single assessment(0)
- PIP - Notification of discontinuation of a paediatric development which is covered by an agreed PIP decision(0)
- PIP - Paediatric-investigation-plan summary(0)
- PIP decision(0)
- Position statement(0)
- PRAC recommendation on signal(0)
- Presentation(0)
- Press Release(0)
- Procurement(0)
- Public Statement(0)
- Recommendation on medication errors(0)
- Recruitment(0)
- Referrals document(0)
- Regulatory and procedural guideline(0)
- Report(1)
- Scientific guideline(0)
- Standard Operating Procedure - SOP(0)
- Summary of opinion(0)
- Summary of opinion - Initial authorisation(0)
- Supply shortage(0)
- Template or form(0)
- Withdrawal letter(0)
- Work Instruction - WIN(0)
- Work programme(0)
- Advanced therapies(0)
- Antimicrobial resistance(0)
- Biologicals(0)
- Biosimilars(0)
- Brexit(0)
- Careers(0)
- Clinical trials(0)
- Compassionate use(0)
- Compliance and inspections(0)
- Corporate(0)
- COVID-19(0)
- Data on medicines(0)
- Early access(0)
- Fees(0)
- Generic and hybrid medicines(0)
- Governance(0)
- Innovation(0)
- Maximum residue limit(0)
- Medication error(0)
- Medicines(2)
- Medicines for use outside the EU(0)
- Medicine shortages(0)
- Mpox(0)
- Paediatrics(0)
- Parallel distribution(0)
- Pharmacovigilance(1)
- Procurement(0)
- Product information(0)
- Quality of medicines(0)
- Rare diseases(0)
- Referrals(0)
- Regulatory and procedural guidance(2)
- Research and development(3)
- Scientific advice(0)
- Scientific guidelines(2)
- SME(0)
- Vaccines(2)
- Veterinary limited markets(0)
Search results (3)
2019 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission - Reporting period: 1 January to 31 December 2019
English (EN) (810.33 KB - PDF)
Minutes of the sixty-third meeting of the Management Board: 11 June 2009
English (EN) (110.84 KB - PDF)
български (BG) (314.11 KB - PDF)
español (ES) (142.08 KB - PDF)
čeština (CS) (254.87 KB - PDF)
dansk (DA) (139.98 KB - PDF)
Deutsch (DE) (142.16 KB - PDF)
eesti keel (ET) (135.28 KB - PDF)
ελληνικά (EL) (306.14 KB - PDF)
français (FR) (143.02 KB - PDF)
italiano (IT) (140.47 KB - PDF)
latviešu valoda (LV) (288.59 KB - PDF)
lietuvių kalba (LT) (253.78 KB - PDF)
magyar (HU) (242.45 KB - PDF)
Malti (MT) (272.78 KB - PDF)
Nederlands (NL) (139.89 KB - PDF)
polski (PL) (258.35 KB - PDF)
português (PT) (141.61 KB - PDF)
română (RO) (248.04 KB - PDF)
slovenčina (SK) (211.31 KB - PDF)
slovenščina (SL) (201.66 KB - PDF)
Suomi (FI) (137.94 KB - PDF)
svenska (SV) (136.94 KB - PDF)
Agenda - Sixty-third meeting of the Management Board, 11 June 2009
English (EN) (28.59 KB - PDF)